Breakout Labs appeared to be the VC, which was created in 2013. The fund was located in North America if to be more exact in United States. The leading representative office of defined VC is situated in the San Francisco.
Besides them, we counted 2 critical employees of this fund in our database.
The typical case for the fund is to invest in rounds with 1-2 participants. Despite the Breakout Labs, startups are often financed by SOSV, Innovation Works, Urban Redevelopment Authority of Pittsburgh. The meaningful sponsors for the fund in investment in the same round are StartX (Stanford-StartX Fund), Partnership Fund for New York City, National Science Foundation. In the next rounds fund is usually obtained by Dolby Family Ventures, Breakout Ventures, Takeda Ventures.
Among the most popular portfolio startups of the fund, we may highlight Modern Meadow, C2Sense, Azitra. The fund has no exact preference in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. Besides, a startup needs to be aged 1 and less years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Chemical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
Opposing the other organizations, this Breakout Labs works on 23 percentage points less the average amount of lead investments. The higher amount of exits for fund were in 2019. Deals in the range of 100 thousands - 1 million dollars are the general things for fund. Considering the real fund results, this VC is 8 percentage points less often commits exit comparing to other organizations. The fund is constantly included in 2-6 deals per year. The top activity for fund was in 2016.
Fund Name | Location |
ACCEL (Norwegian Accelerator) | Bergen, Hordaland, Norway |
Aspen Highland Partners | - |
Chong Kun Dang Pharmaceutical Corp. | Seoul, Seoul-t'ukpyolsi, South Korea |
Daman Investments | Dubai, United Arab Emirates |
Diverse Middle East FZE | - |
GNI Group | - |
Group8 | - |
Invariantes Fund | Guatemala, Guatemala City |
JAIC Asia Capital | Central, Central Region, Singapore |
MAD Ventures | British Columbia, Canada, Victoria |
MAN Truck & Bus | Bayern, Germany, Munich |
Motian Star | China, Guangdong, Shenzhen |
QianMing Capital | China, Shanghai |
Redhawk VC | Alabama, Birmingham, United States |
TempoCap | England, London, United Kingdom |
The Scoular Company | Nebraska, Omaha, United States |
TOWA INVESTMENT | Hokkaido Prefecture, Japan, Sapporo |
US Angel Investors | California, Palo Alto, United States |
Wismichu | - |
Zhejiang Sunflower Light Energy Science&Technology | China, Shaoxing, Zhejiang |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Napigen, Inc. | $7M | 12 Jul 2022 | Wilmington, Delaware, United States | ||
Glyscend | 24 Jul 2019 | Baltimore, Maryland, United States | |||
Napigen, Inc. | 30 Apr 2019 | Wilmington, Delaware, United States | |||
Nuclease Probe Technologies | $500K | 07 Mar 2019 | - | ||
scibac | 10 Oct 2018 | California, United States | |||
Orion BioScience | 01 Oct 2018 | - | |||
Pelitex | 11 Aug 2018 | Syracuse, New York, United States | |||
Peroxygen Systems | 09 May 2018 | Knoxville, Tennessee, United States | |||
Ras Labs | 19 Oct 2017 | Quincy, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Napigen, Inc. | $7M | 12 Jul 2022 | Wilmington, Delaware, United States | ||
Glyscend | 24 Jul 2019 | Baltimore, Maryland, United States | |||
Napigen, Inc. | 30 Apr 2019 | Wilmington, Delaware, United States | |||
Nuclease Probe Technologies | $500K | 07 Mar 2019 | - | ||
scibac | 10 Oct 2018 | California, United States | |||
Orion BioScience | 01 Oct 2018 | - | |||
Pelitex | 11 Aug 2018 | Syracuse, New York, United States | |||
Peroxygen Systems | 09 May 2018 | Knoxville, Tennessee, United States | |||
Ras Labs | 19 Oct 2017 | Quincy, Massachusetts, United States |